Comorbidities of migraine

Migraine is a common neurological disorder and can be severely disabling during attacks. The highest prevalence occurs between the ages of 25 and 55 years, potentially the most productive period of life. Migraine leads to a burden not only for the individual, but also for the family and society in g...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 1; p. 16
Main Authors Wang, Shuu-Jiun, Chen, Ping-Kun, Fuh, Jong-Ling
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Migraine is a common neurological disorder and can be severely disabling during attacks. The highest prevalence occurs between the ages of 25 and 55 years, potentially the most productive period of life. Migraine leads to a burden not only for the individual, but also for the family and society in general. Prior studies have found that migraine occurs together with other illnesses at a greater coincidental rate than is seen in the general population. These occurrences are called "comorbidities," which means that these disorders are interrelated with migraine. To delineate the comorbidities of migraine is important, because it can help improve treatment strategies and the understanding of the possible pathophysiology of migraine. The comorbid illnesses in patients with migraine include stroke, sub-clinical vascular brain lesions, coronary heart disease, hypertension, patent foramen ovale, psychiatric diseases (depression, anxiety, bipolar disorder, panic disorder, and suicide), restless legs syndrome, epilepsy and asthma. In this paper, we review the existing epidemiological and hospital-based studies, and illustrate the connections between these illnesses and migraine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Mario Peres, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Reviewed by: Giancarlo Luchetti, Centro de Terapia Intensiva, Hospital de Aeronáutica de São Paulo, Brazil; Marcelo Valença, Federal University of Pernambuco, Brazil
This article was submitted to Frontiers in Headache Medicine and Facial Pain, a specialty of Frontiers in Neurology.
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2010.00016